The use of prior distributions in the design of experiments for 450 parameter estimation in non-linear situations: multiresponse case, Biometrika. 448 Biometrika, vol.4654, issue.23, pp.77-90662, 1959. ,
The Design of Experiments for Parameter Estimation, Technometrics, vol.17, issue.2, p.453 ,
DOI : 10.1080/00401706.1968.10490560
Optimum Experimental Design, 457 6. D'Argenio DZ. Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems 458 ,
DOI : 10.1007/978-3-642-04898-2_434
Optimal Design for Nonlinear Response Models, Boca Raton, p.460 ,
Optimal design for individual parameter estimation in pharmacokinetics ,
Robust experimental design via maximin optimization, Math Biosci, vol.46489, issue.465, pp.161-76, 1988. ,
DOI : 10.1016/0025-5564(88)90097-1
Application of the Optimal Design Approach to Improve a Pretransplant Drug Dose Finding Design for Ciclosporin, The Journal of Clinical Pharmacology, vol.39, issue.3, pp.347-60, 2012. ,
DOI : 10.1177/0091270010397731
Designing an optimal experiment for Bayesian 469 estimation: application to the kinetics of iodine thyroid uptake, Stat Med. Epub, vol.1330, issue.471, pp.185-96, 1994. ,
Evaluation of methods for estimating population pharmacokinetic 472 parameters. III. Monoexponential model: routine clinical pharmacokinetic data, J Pharmacokinet, p.473 ,
Experimental design and efficient parameter estimation in population pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.46, issue.4, pp.347-60, 1990. ,
DOI : 10.1007/BF01062273
Analysis of animal pharmacokinetic data, p.477 ,
Comparison of some practical sampling strategies for population pharmacokinetic studies, Journal of Pharmacokinetics and Biopharmaceutics, vol.19, issue.2, pp.245-63, 1996. ,
DOI : 10.1007/BF02353491
Balanced designs in longitudinal population pharmacokinetic 482 studies, 483 17. U.S. Department of Health and Human Services FaDA. Guidance for Industry, pp.417-440, 1998. ,
Optimal design in random-effects regression models, Biometrika, vol.84, issue.2, p.486 ,
DOI : 10.1093/biomet/84.2.429
Biometrika: One Hundred Years, Biometrika, vol.84, issue.20, pp.429-471, 1997. ,
Development and implementation of the population Fisher 490 information matrix for the evaluation of population pharmacokinetic designs, Comput Methods, p.491 ,
Some considerations on the design of population 493 ,
POPED, a software for optimal experiment design 495 in population kinetics Comput Meth Prog Bio A program for individual and 497 population optimal design for univariate and multivariate response pharmacokinetic- 498 pharmacodynamic models, Comput Methods Programs Biomed, vol.7486, issue.499, pp.29-4651, 2004. ,
PkStaMp Library for Constructing Optimal 500 ,
Current use and 502 developments needed for optimal design in pharmacometrics : a study performed amongst 503 ,
DDMoRe's EFPIA members. 2012. 504 26, p.505 ,
PopED: an extended, 508 parallelized, nonlinear mixed effects models optimal design tool Comput Methods Programs 509 ,
OPTIMAL POPULATION DESIGNS FOR PK MODELS WITH SERIAL SAMPLING, Journal of Biopharmaceutical Statistics, vol.13, issue.1, p.511 ,
DOI : 10.1002/0471725315
Incorporating correlation in 513 interindividual variability for the optimal design of multiresponse pharmacokinetic experiments, Biopharm Stat. J, vol.1511, issue.514, pp.143-63, 2005. ,
Further developments of the Fisher information matrix in nonlinear 516 mixed effects models with evaluation in population pharmacokinetics, J Biopharm Stat, vol.51713, issue.518, pp.209-236, 2003. ,
poped, a software for optimal experiment design in population kinetics, Computer Methods and Programs in Biomedicine, vol.74, issue.1, pp.29-46, 2004. ,
DOI : 10.1016/S0169-2607(03)00073-7
Optimal design for population pk/pd models, Tatra Mountains Mathematical Publications, vol.51, issue.1, pp.115-145, 2012. ,
DOI : 10.2478/v10127-012-0012-1
Some Considerations on the Fisher Information in Nonlinear Mixed 523 ,
525 34, J Clin Invest, vol.42, issue.527, pp.129-165, 1963. ,
Design evaluation and optimisation in multiple response 528 ,
Design in nonlinear mixed effects models: Optimization using the Fedorov???Wynn algorithm and power of the Wald test for binary covariates, Statistics in Medicine, vol.39, issue.28, p.532 ,
DOI : 10.1002/sim.2910
URL : https://hal.archives-ouvertes.fr/hal-00263513
Studies on coumarin anticoagulant drugs. Initiation of warfarin 534 therapy without a loading dose, Stat Med. Circulation, vol.2638, issue.535, pp.5162-7905, 1968. ,
Design evaluation and optimization for models of hepatitis C viral dynamics, Statistics in Medicine, vol.38, issue.18, pp.1045-5602, 2011. ,
DOI : 10.1002/sim.4191
URL : https://hal.archives-ouvertes.fr/inserm-00615142
Hepatitis C viral 538 dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, Science, vol.53928210, issue.5386, pp.103-702, 1998. ,